In 2024, the forecast for China's antibiotics imports stands at $539.4 million, a figure projected to grow steadily year-on-year, reaching $575.59 million by 2028. This indicates an upward trend driven by increasing healthcare demands, modernization of medical facilities, and the rising prevalence of antibiotic-resistant infections. The annual growth rate from 2024 to 2028 ranges between 1.7% and 1.6%, reflecting moderate but consistent expansion.

Highlights for future trends to watch for:

Impact of domestic pharmaceutical manufacturing capacity increases on import needs.
China's evolving healthcare policies and import regulations.
Global antibiotic supply chain dynamics and technological advancements in synthetic biology.